通过天然产品柏比林来更高的选择性准端粒多重体G-四重体
Jixin Chen1, Yi He1, Yang Xu2
1National R&D Center for Se-rich Agricultural Products Processing, Hubei Engineering Research Center for Deep Processing of Green Se-rich Agricultural Products, School of Modern Industry for Selenium Science and Engineering, Wuhan Polytechnic University, Wuhan, 430023, China.
Current medicinal chemistry
|February 12, 2025
概括
柏柏林选择性地向端粒多重体G-四复合体 (G4s),结合到特定的部位并诱导DNA损伤. 这种天然产品在开发针对G4结构的新型抗瘤药物方面表现有前途.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- G四重复体 (G4s) 是DNA/RNA结构,具有作为抗瘤药物点的潜力.
- 选择性对特定G4s的结合仍然是一个重大挑战.
- 与单体G4s相比,Telomeric多重体G4s为连接体查提供了更好的可访问性.
研究的目的:
- 为了研究天然产品贝贝林对端粒多重体G四重体的选择性.
- 阐明柏柏林与端粒G4s之间的相互作用机制.
- 探索柏柏林作为一种向G4结构的抗瘤剂的潜力.
主要方法:
- 光光谱测量,工作图分析和紫外线定位被用于研究柏柏林-G4相互作用.
- 动态光散射 (DLS) 和原生聚烯胺凝电泳 (原生PAGE) 评估了形状变化.
- 免疫光分析检测到内源G4形成和DNA损伤反应.
主要成果:
- 柏柏林对端粒多重体G4比其他G4s具有很高的选择性.
- 在二维G-四重复Tel45上发现了三个柏林的结合位,其中偏好于界面腔.
- 柏柏林结合增加了端粒多重体G4s的粒子大小,并诱导了端粒DNA损伤反应.
结论:
- 柏柏林选择性地与端粒多重体G四重体相互作用.
- 这些发现支持开发天然产品,如柏柏林,作为向抗瘤药物.
- 柏柏林诱导G4形成和DNA损伤的能力突显了其治疗潜力.
相关概念视频
Telomeres and Telomerase
23.0K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.0K
Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


